Bank Of Montreal

Direxion Daily Small Cap Bull 3X ETF

SPDR S&P Retail ETF

ProShares UltraPro Dow30

ProShares UltraShort Bloomberg Natrl Gas

Guggenheim Solar ETF

Direxion Technology Bear 3X Shares

Materials Select Sector SPDR

ProShares Trust ProShares Short Bitcoin Strategy ETF

ProShares Bitcoin Strategy ETF

Direxion Daily Small Cap Bear 3X ETF

ProShares Ultra Bloomberg Natural Gas

Direxion Daily Technology Bull 3X ETF

ARK Innovation ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

Magal Security Systems Ltd.

Direxion Financial Bear 3X Shar

Direxion Daily Semicondct Bull 3X ETF

JELD-WEN Holding Inc. Common Stock

Las Vegas Sands Corp. Common Stock

Century Communities Inc. Common Stock

Kontoor Brands Inc. Common Stock

Bath & Body Works Inc.

RLJ Lodging Trust Common Shares of Beneficial Interest $0.01 par value

Leggett & Platt Incorporated Common Stock

Snap Inc. Class A Common Stock

Cleveland-Cliffs Inc. Common Stock

Civitas Resources Inc. Common Stock

Archer Aviation Inc. Class A Common Stock

AMC Entertainment Holdings Inc. Class A Common Stock

Oklo Inc.

QuantumScape Corporation Class A Common Stock

Sea Limited American Depositary Shares each representing one Class A Ordinary Share

Cameco Corporation Common Stock

Twilio Inc. Class A Common Stock

Spotify Technology S.A. Ordinary Shares

Cloudflare Inc. Class A Common Stock

Molina Healthcare Inc Common Stock

Click here to get full coverage on Market Sentiment Around Loss-Making Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) - simplywall.st

Market Sentiment Around Loss-Making Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)  simplywall.st

Market Sentiment Around Loss-Making Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) - simplywall.st

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Target Price Raised by Citigroup | ALNY Stock News - GuruFocus

Alnylam Pharmaceuticals (ALNY) Target Price Raised by Citigroup | ALNY Stock News  GuruFocus

Alnylam Pharmaceuticals (ALNY) Target Price Raised by Citigroup | ALNY Stock News - GuruFocus

Click here to get full coverage on Alnylam Pharmaceuticals Inc (ALNY) Q1 2025 Earnings Call Highlights: Robust Revenue Growth and ... - Yahoo Finance

Alnylam Pharmaceuticals Inc (ALNY) Q1 2025 Earnings Call Highlights: Robust Revenue Growth and ...  Yahoo Finance

Alnylam Pharmaceuticals Inc (ALNY) Q1 2025 Earnings Call Highlights: Robust Revenue Growth and ... - Yahoo Finance

Click here to get full coverage on Earnings Preview: RNAi Leader Alnylam Set to Unveil Q1 2025 Performance May 1 - What to Watch - Stock Titan

Earnings Preview: RNAi Leader Alnylam Set to Unveil Q1 2025 Performance May 1 - What to Watch  Stock Titan

Earnings Preview: RNAi Leader Alnylam Set to Unveil Q1 2025 Performance May 1 - What to Watch - Stock Titan

Click here to get full coverage on Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results - Business Wire

Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results  Business Wire

Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results - Business Wire

Click here to get full coverage on Alnylam Pharmaceuticals: Commercialization And Early-Stage Studies Are Likely To Drive 2025 - Seeking Alpha

Alnylam Pharmaceuticals: Commercialization And Early-Stage Studies Are Likely To Drive 2025  Seeking Alpha

Alnylam Pharmaceuticals: Commercialization And Early-Stage Studies Are Likely To Drive 2025 - Seeking Alpha

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release  Yahoo Finance

Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance

Click here to get full coverage on RNAi Leader Alnylam Set for Major Presentation at Goldman Sachs Healthcare Conference - Stock Titan

RNAi Leader Alnylam Set for Major Presentation at Goldman Sachs Healthcare Conference  Stock Titan

RNAi Leader Alnylam Set for Major Presentation at Goldman Sachs Healthcare Conference - Stock Titan

Click here to get full coverage on Alnylam to Share Progress Across its Transthyretin Amyloidosis Franchise Including Additional Analyses of the HELIOS-B Phase 3 Study Results at Heart Failure 2025 Congress - Business Wire

Alnylam to Share Progress Across its Transthyretin Amyloidosis Franchise Including Additional Analyses of the HELIOS-B Phase 3 Study Results at Heart Failure 2025 Congress  Business Wire

Alnylam to Share Progress Across its Transthyretin Amyloidosis Franchise Including Additional Analyses of the HELIOS-B Phase 3 Study Results at Heart Failure 2025 Congress - Business Wire

Click here to get full coverage on Alnylam (ALNY) Moves 8.5% Higher: Will This Strength Last? - Yahoo Finance

Alnylam (ALNY) Moves 8.5% Higher: Will This Strength Last?  Yahoo Finance

Alnylam (ALNY) Moves 8.5% Higher: Will This Strength Last? - Yahoo Finance

Click here to get full coverage on Alnylam ESG Report: 100% Renewable Energy Sites, 88% Employee Satisfaction Score Revealed - Stock Titan

Alnylam ESG Report: 100% Renewable Energy Sites, 88% Employee Satisfaction Score Revealed  Stock Titan

Alnylam ESG Report: 100% Renewable Energy Sites, 88% Employee Satisfaction Score Revealed - Stock Titan

Click here to get full coverage on Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Performing Biotech Stock in 2024? - Yahoo Finance

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Performing Biotech Stock in 2024?  Yahoo Finance

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Performing Biotech Stock in 2024? - Yahoo Finance

Click here to get full coverage on Alnylam (ALNY) Surges 11.8%: Is This an Indication of Further Gains? - Yahoo Finance

Alnylam (ALNY) Surges 11.8%: Is This an Indication of Further Gains?  Yahoo Finance

Alnylam (ALNY) Surges 11.8%: Is This an Indication of Further Gains? - Yahoo Finance

Click here to get full coverage on Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight - Yahoo Finance

Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight  Yahoo Finance

Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Beats Q4 Earnings and Revenue Estimates  Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on Biotech Stock Roundup: SAVA Dives on Setback, ALNY Up on Update & More - Yahoo Finance

Biotech Stock Roundup: SAVA Dives on Setback, ALNY Up on Update & More  Yahoo Finance

Biotech Stock Roundup: SAVA Dives on Setback, ALNY Up on Update & More - Yahoo Finance

Click here to get full coverage on GILD vs. ALNY: Which Stock Is the Better Value Option? - Yahoo Finance

GILD vs. ALNY: Which Stock Is the Better Value Option?  Yahoo Finance

GILD vs. ALNY: Which Stock Is the Better Value Option? - Yahoo Finance

Click here to get full coverage on ALNY Announces Preliminary 2024 Results, 2025 View & Pipeline Goals - Yahoo Finance

ALNY Announces Preliminary 2024 Results, 2025 View & Pipeline Goals  Yahoo Finance

ALNY Announces Preliminary 2024 Results, 2025 View & Pipeline Goals - Yahoo Finance

Click here to get full coverage on Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics - Yahoo Finance

Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics  Yahoo Finance

Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics - Yahoo Finance

Click here to get full coverage on Seeking Clues to Alnylam (ALNY) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics - Yahoo Finance

Seeking Clues to Alnylam (ALNY) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics  Yahoo Finance

Seeking Clues to Alnylam (ALNY) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics - Yahoo Finance

Click here to get full coverage on XBI, ALNY, EXEL, UTHR: Large Inflows Detected at ETF - Nasdaq

XBI, ALNY, EXEL, UTHR: Large Inflows Detected at ETF  Nasdaq

XBI, ALNY, EXEL, UTHR: Large Inflows Detected at ETF - Nasdaq

Click here to get full coverage on BMO Capital Maintains ‘Outperform’ Rating on Alnylam Pharmaceuticals, Inc. (ALNY); Raises PT - MSN

BMO Capital Maintains ‘Outperform’ Rating on Alnylam Pharmaceuticals, Inc. (ALNY); Raises PT  MSN

BMO Capital Maintains ‘Outperform’ Rating on Alnylam Pharmaceuticals, Inc. (ALNY); Raises PT - MSN

Click here to get full coverage on Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year? - Yahoo Finance

Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?  Yahoo Finance

Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year? - Yahoo Finance

Click here to get full coverage on Alnylam's Vutrisiran FDA Review Set for ATTR-CM Treatment Expansion - Stock Titan

Alnylam's Vutrisiran FDA Review Set for ATTR-CM Treatment Expansion  Stock Titan

Alnylam's Vutrisiran FDA Review Set for ATTR-CM Treatment Expansion - Stock Titan

Click here to get full coverage on Needham Raises Price Target for Alnylam Pharmaceuticals (ALNY) to $377 | ALNY Stock News - GuruFocus

Needham Raises Price Target for Alnylam Pharmaceuticals (ALNY) to $377 | ALNY Stock News  GuruFocus

Needham Raises Price Target for Alnylam Pharmaceuticals (ALNY) to $377 | ALNY Stock News - GuruFocus

Click here to get full coverage on Alnylam Pharmaceuticals Stock (ALNY): Innovative Treatment for ATTR Amyloidosis - Value The Markets

Alnylam Pharmaceuticals Stock (ALNY): Innovative Treatment for ATTR Amyloidosis  Value The Markets

Alnylam Pharmaceuticals Stock (ALNY): Innovative Treatment for ATTR Amyloidosis - Value The Markets

Click here to get full coverage on ALNYLAM PHARMACEUTICALS Earnings Results: $ALNY Reports Quarterly Earnings - Quiver Quantitative

ALNYLAM PHARMACEUTICALS Earnings Results: $ALNY Reports Quarterly Earnings  Quiver Quantitative

ALNYLAM PHARMACEUTICALS Earnings Results: $ALNY Reports Quarterly Earnings - Quiver Quantitative

Click here to get full coverage on Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer - Business Wire

Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer  Business Wire

Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer - Business Wire

Click here to get full coverage on Here's Why You Should Add ALNY Stock to Your Portfolio Right Now - Yahoo Finance

Here's Why You Should Add ALNY Stock to Your Portfolio Right Now  Yahoo Finance

Here's Why You Should Add ALNY Stock to Your Portfolio Right Now - Yahoo Finance

Click here to get full coverage on Breakthrough: New FDA-Approved Heart Disease Drug Cuts Death Risk by 36% - Stock Titan

Breakthrough: New FDA-Approved Heart Disease Drug Cuts Death Risk by 36%  Stock Titan

Breakthrough: New FDA-Approved Heart Disease Drug Cuts Death Risk by 36% - Stock Titan

Click here to get full coverage on Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y - TradingView

Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y  TradingView

Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y - TradingView

Click here to get full coverage on Seeking Clues to Alnylam (ALNY) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics - Yahoo Finance

Seeking Clues to Alnylam (ALNY) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics  Yahoo Finance

Seeking Clues to Alnylam (ALNY) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics - Yahoo Finance

Click here to get full coverage on Buy, Sell, Or Hold Alnylam Stock At $280? - Forbes

Buy, Sell, Or Hold Alnylam Stock At $280?  Forbes

Buy, Sell, Or Hold Alnylam Stock At $280? - Forbes

Click here to get full coverage on Growth Stock Portfolio: 12 Companies with At Least 30% Annual Growth Rates - Insider Monkey

Growth Stock Portfolio: 12 Companies with At Least 30% Annual Growth Rates  Insider Monkey

Growth Stock Portfolio: 12 Companies with At Least 30% Annual Growth Rates - Insider Monkey

Click here to get full coverage on SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Alnylam Pharmaceuticals, Inc. (ALNY) - ACCESS Newswire

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Alnylam Pharmaceuticals, Inc. (ALNY)  ACCESS Newswire

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Alnylam Pharmaceuticals, Inc. (ALNY) - ACCESS Newswire

Click here to get full coverage on Alnylam sees 2024 net product revenues of over $1.6B, up 33% Y/Y (NASDAQ:ALNY) - Seeking Alpha

Alnylam sees 2024 net product revenues of over $1.6B, up 33% Y/Y (NASDAQ:ALNY)  Seeking Alpha

Alnylam sees 2024 net product revenues of over $1.6B, up 33% Y/Y (NASDAQ:ALNY) - Seeking Alpha

Click here to get full coverage on Alnylam Pharmaceuticals Q3 Earnings Preview: Key RNAi Catalysts To Watch (NASDAQ:ALNY) - Seeking Alpha

Alnylam Pharmaceuticals Q3 Earnings Preview: Key RNAi Catalysts To Watch (NASDAQ:ALNY)  Seeking Alpha

Alnylam Pharmaceuticals Q3 Earnings Preview: Key RNAi Catalysts To Watch (NASDAQ:ALNY) - Seeking Alpha

Click here to get full coverage on Biotech Stock Roundup: NVAX Vaccine Approval, ALNY, ATHA Stock Dive on Updates & More - Yahoo Finance

Biotech Stock Roundup: NVAX Vaccine Approval, ALNY, ATHA Stock Dive on Updates & More  Yahoo Finance

Biotech Stock Roundup: NVAX Vaccine Approval, ALNY, ATHA Stock Dive on Updates & More - Yahoo Finance

Click here to get full coverage on Alnylam's Clinical Breakthrough: 36% Mortality Reduction and 9 New Drug Candidates by 2025 - Stock Titan

Alnylam's Clinical Breakthrough: 36% Mortality Reduction and 9 New Drug Candidates by 2025  Stock Titan

Alnylam's Clinical Breakthrough: 36% Mortality Reduction and 9 New Drug Candidates by 2025 - Stock Titan

Click here to get full coverage on XBI, EXAS, ALNY, NTRA: Large Outflows Detected at ETF - Nasdaq

XBI, EXAS, ALNY, NTRA: Large Outflows Detected at ETF  Nasdaq

XBI, EXAS, ALNY, NTRA: Large Outflows Detected at ETF - Nasdaq

Click here to get full coverage on ALNY Down Despite Positive Data From Heart Disease Drug Study - Yahoo Finance

ALNY Down Despite Positive Data From Heart Disease Drug Study  Yahoo Finance

ALNY Down Despite Positive Data From Heart Disease Drug Study - Yahoo Finance

Click here to get full coverage on Alnylam stock poised for strong quarter as Amvuttra launch gains traction - Investing.com

Alnylam stock poised for strong quarter as Amvuttra launch gains traction  Investing.com

Alnylam stock poised for strong quarter as Amvuttra launch gains traction - Investing.com

Click here to get full coverage on Alnylam Pharmaceuticals Inc (ALNY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook - GuruFocus

Alnylam Pharmaceuticals Inc (ALNY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook  GuruFocus

Alnylam Pharmaceuticals Inc (ALNY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook - GuruFocus

Click here to get full coverage on Alnylam price target raised to $359 from $336 at BofA - TipRanks

Alnylam price target raised to $359 from $336 at BofA  TipRanks

Alnylam price target raised to $359 from $336 at BofA - TipRanks

Click here to get full coverage on Moderna Beats Alnylam Appeal In COVID Vaccine Patent Case - Benzinga

Moderna Beats Alnylam Appeal In COVID Vaccine Patent Case  Benzinga

Moderna Beats Alnylam Appeal In COVID Vaccine Patent Case - Benzinga

Click here to get full coverage on Alnylam Rallies 62% in a Year: Can the Stock Maintain This Momentum? - Yahoo Finance

Alnylam Rallies 62% in a Year: Can the Stock Maintain This Momentum?  Yahoo Finance

Alnylam Rallies 62% in a Year: Can the Stock Maintain This Momentum? - Yahoo Finance

Click here to get full coverage on Alnylam stock target raised to $390 at Canaccord Genuity - Investing.com

Alnylam stock target raised to $390 at Canaccord Genuity  Investing.com

Alnylam stock target raised to $390 at Canaccord Genuity - Investing.com

Click here to get full coverage on Alnylam Pharma Re-elects Directors at Annual Meeting - TipRanks

Alnylam Pharma Re-elects Directors at Annual Meeting  TipRanks

Alnylam Pharma Re-elects Directors at Annual Meeting - TipRanks

Click here to get full coverage on H.C. Wainwright raises Alnylam stock target to $500, maintains Buy - Investing.com

H.C. Wainwright raises Alnylam stock target to $500, maintains Buy  Investing.com

H.C. Wainwright raises Alnylam stock target to $500, maintains Buy - Investing.com

Click here to get full coverage on Biggest stock movers Friday: NIO, ALNY, FDX, and more - MSN

Biggest stock movers Friday: NIO, ALNY, FDX, and more  MSN

Biggest stock movers Friday: NIO, ALNY, FDX, and more - MSN

Click here to get full coverage on Alnylam Pharmaceuticals Reports Strong 2024 Growth - TipRanks

Alnylam Pharmaceuticals Reports Strong 2024 Growth  TipRanks

Alnylam Pharmaceuticals Reports Strong 2024 Growth - TipRanks

Click here to get full coverage on How Alnylam Is Taking On Pfizer In A Massive, Growing Market - Investor's Business Daily

How Alnylam Is Taking On Pfizer In A Massive, Growing Market  Investor's Business Daily

How Alnylam Is Taking On Pfizer In A Massive, Growing Market - Investor's Business Daily

Click here to get full coverage on Alnylam CEO’s compensation package continues to grow - The Business Journals

Alnylam CEO’s compensation package continues to grow  The Business Journals

Alnylam CEO’s compensation package continues to grow - The Business Journals

Click here to get full coverage on Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy - Yahoo Finance

Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy  Yahoo Finance

Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy - Yahoo Finance

Click here to get full coverage on Alnylam: HELIOS-B Success Priced In Already (NASDAQ:ALNY) - Seeking Alpha

Alnylam: HELIOS-B Success Priced In Already (NASDAQ:ALNY)  Seeking Alpha

Alnylam Pharmaceuticals Inc (ALNY)

Price Chart

Key Statistics

Technicals

About ALNY

Latest News

Market Sentiment Around Loss-Making Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) - simplywall.st

Alnylam Pharmaceuticals (ALNY) Target Price Raised by Citigroup | ALNY Stock News - GuruFocus

Alnylam Pharmaceuticals Inc (ALNY) Q1 2025 Earnings Call Highlights: Robust Revenue Growth and ... - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers